Sarepta reported a third death tied to its gene therapies.
Related Posts
Stock futures tick higher after Dow ends three-day winning run: Live updates
The three major averages are on track for modest weekly gains.
Stock futures are flat as Wall Street readies for presidential election: Live updates
Investors readied for a high-stakes U.S. presidential election.
Perplexity AI seeks valuation of about $9 billion in new funding round
Perplexity started the year with a roughly $500 million valuation and has continued attracting significant investor interest alongside the generative AI boom.